News

Under the terms of this financing, investments will be made in three tranches: $12 million before March 31, 2009, $12 million before December 31, 2009 and $12 million

The AdnaTest diagnostic and analytical products for breast and colon cancer are aimed at improving cancer prognosis and patient management. The tests are based on immunomagnetic selection of

Additionally, the company will conduct a voluntary recall of most of its products. The scope and depth of the recall are currently under discussion with the FDA. These

Irinotecan is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. This product is available for

According to the company, the Talent abdominal stent graft expands the applicability of endovascular aneurysm repair, enabling more patients to benefit from a minimally invasive alternative to open

The FiberNet embolic protection system (EPS), which received the FDA clearance in November 2008, is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease.

The complex human EGF receptor (HER) family of receptors and growth factor ligands is dysregulated in about half of all solid cancers. Receptor BioLogix’s pan-HER ligand traps are

Under the terms of the agreement, CPC Scientific will offer Sigma-Aldrich’s PEPscreen custom peptide libraries to life science researchers and pharmaceutical companies in North America. Sigma-Aldrich has developed

These trials are the first step toward the FDA clinical trials to test the efficacy of using International Stem Cell Corporation (ISCO) cells to improve healing after corneal